On January 22, 2010, the U.S. Court of Appeals for the Federal Circuit affirmed the U.S. District Court for the District of Delaware decision that Takeda Pharmaceutical Co. Ltd. did not prove infringement in its case against Teva Pharmaceutical Industries Ltd. over Teva's generic version of the acid reflux drug PREVACID® SOLU-TABs™. Sutherland was mentioned for representing Teva. John North and Jeff Toney were lead trial counsel for Teva.